neostigmine has been researched along with Premature Birth in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).
Excerpt | Relevance | Reference |
---|---|---|
"We compared miscarriages and preterm births within four weeks after surgery." | 1.91 | Fetal outcomes with and without the use of sugammadex in pregnant patients undergoing non-obstetric surgery: a multicenter retrospective study. ( Ishida, Y; Iwasaki, H; Kawasaki, Y; Mazda, Y; Noguchi, S; Ono Uokawa, R; Shiko, Y; Shinomiya, S, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Noguchi, S | 1 |
Iwasaki, H | 1 |
Shiko, Y | 1 |
Kawasaki, Y | 1 |
Ishida, Y | 1 |
Shinomiya, S | 1 |
Ono Uokawa, R | 1 |
Mazda, Y | 1 |
1 other study available for neostigmine and Premature Birth
Article | Year |
---|---|
Fetal outcomes with and without the use of sugammadex in pregnant patients undergoing non-obstetric surgery: a multicenter retrospective study.
Topics: Abortion, Spontaneous; Female; Humans; Infant, Newborn; Neostigmine; Pregnancy; Pregnancy Outcome; P | 2023 |